Clinical outcomes of helical conformal versus nonconformal palliative radiation therapy for axial skeletal metastases

Kara D. Romano, Daniel Trifiletti, Kristine Bauer-Nilsen, Nolan A. Wages, William T. Watkins, Paul W. Read, Timothy N. Showalter

Research output: Contribution to journalArticle

Abstract

Purpose Palliative radiation therapy (RT) for bone metastases has traditionally been delivered with conventional, nonconformal RT (NCRT). Conformal RT (CRT) is potentially more complex and expensive than NCRT, but may reduce normal tissue dose and subsequently toxicity. In this retrospective analysis, we compared CRT with NCRT to investigate the association between conformality and toxicity. Methods and materials A retrospective analysis of patients receiving palliative RT for axial skeletal bone metastases from 2012 to 2014 was conducted. Patient and treatment characteristics were obtained including dosimetric variables, acute toxicity, and subjective pain during treatment and in the acute posttreatment period (≤60 days after completion). Statistical analyses included t tests, χ2 tests, and multivariate logistic regression. Results A total of 179 patients and 254 bone metastases were identified (142 CRT, 112 NCRT). The CRT and NCRT groups were well matched for baseline characteristics (number of fractions, field size, treatment sites, and concurrent chemotherapy). In multivariate logistic regression models, technique (CRT vs NCRT) was not associated with development of acute toxicity. Regarding toxicity, Eastern Cooperative Oncology Group performance status and total dose were significantly associated with a higher rate of acute toxicity during RT (odds ratios, 0.649 and 1.129 and P = .027 and .044, respectively), and only a higher number of vertebral bodies in the treatment field was significantly associated with acute toxicity post-treatment (odds ratios, 1.219, P = .028). CRT was associated with improvement in bone pain during and posttreatment (P = .049 and .045, respectively). Conclusions Our results demonstrate no difference in acute toxicity following palliative RT with CRT compared with NCRT for painful bone metastases; however, treatment volume did predict for increased toxicity. Larger studies may further elucidate the value of CRT including the impact of dose escalation for bone metastases and differences in patient reported outcomes between RT techniques.

Original languageEnglish (US)
Pages (from-to)e479-e487
JournalPractical Radiation Oncology
Volume7
Issue number6
DOIs
StatePublished - Nov 1 2017
Externally publishedYes

Fingerprint

Palliative Care
Radiotherapy
Neoplasm Metastasis
Bone and Bones
Logistic Models
Therapeutics
Odds Ratio
Pain
Drug Therapy

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Clinical outcomes of helical conformal versus nonconformal palliative radiation therapy for axial skeletal metastases. / Romano, Kara D.; Trifiletti, Daniel; Bauer-Nilsen, Kristine; Wages, Nolan A.; Watkins, William T.; Read, Paul W.; Showalter, Timothy N.

In: Practical Radiation Oncology, Vol. 7, No. 6, 01.11.2017, p. e479-e487.

Research output: Contribution to journalArticle

Romano, Kara D. ; Trifiletti, Daniel ; Bauer-Nilsen, Kristine ; Wages, Nolan A. ; Watkins, William T. ; Read, Paul W. ; Showalter, Timothy N. / Clinical outcomes of helical conformal versus nonconformal palliative radiation therapy for axial skeletal metastases. In: Practical Radiation Oncology. 2017 ; Vol. 7, No. 6. pp. e479-e487.
@article{93bcfef8c43d4bf99a510305bd7c7c07,
title = "Clinical outcomes of helical conformal versus nonconformal palliative radiation therapy for axial skeletal metastases",
abstract = "Purpose Palliative radiation therapy (RT) for bone metastases has traditionally been delivered with conventional, nonconformal RT (NCRT). Conformal RT (CRT) is potentially more complex and expensive than NCRT, but may reduce normal tissue dose and subsequently toxicity. In this retrospective analysis, we compared CRT with NCRT to investigate the association between conformality and toxicity. Methods and materials A retrospective analysis of patients receiving palliative RT for axial skeletal bone metastases from 2012 to 2014 was conducted. Patient and treatment characteristics were obtained including dosimetric variables, acute toxicity, and subjective pain during treatment and in the acute posttreatment period (≤60 days after completion). Statistical analyses included t tests, χ2 tests, and multivariate logistic regression. Results A total of 179 patients and 254 bone metastases were identified (142 CRT, 112 NCRT). The CRT and NCRT groups were well matched for baseline characteristics (number of fractions, field size, treatment sites, and concurrent chemotherapy). In multivariate logistic regression models, technique (CRT vs NCRT) was not associated with development of acute toxicity. Regarding toxicity, Eastern Cooperative Oncology Group performance status and total dose were significantly associated with a higher rate of acute toxicity during RT (odds ratios, 0.649 and 1.129 and P = .027 and .044, respectively), and only a higher number of vertebral bodies in the treatment field was significantly associated with acute toxicity post-treatment (odds ratios, 1.219, P = .028). CRT was associated with improvement in bone pain during and posttreatment (P = .049 and .045, respectively). Conclusions Our results demonstrate no difference in acute toxicity following palliative RT with CRT compared with NCRT for painful bone metastases; however, treatment volume did predict for increased toxicity. Larger studies may further elucidate the value of CRT including the impact of dose escalation for bone metastases and differences in patient reported outcomes between RT techniques.",
author = "Romano, {Kara D.} and Daniel Trifiletti and Kristine Bauer-Nilsen and Wages, {Nolan A.} and Watkins, {William T.} and Read, {Paul W.} and Showalter, {Timothy N.}",
year = "2017",
month = "11",
day = "1",
doi = "10.1016/j.prro.2017.04.002",
language = "English (US)",
volume = "7",
pages = "e479--e487",
journal = "Practical Radiation Oncology",
issn = "1879-8500",
publisher = "Elsevier BV",
number = "6",

}

TY - JOUR

T1 - Clinical outcomes of helical conformal versus nonconformal palliative radiation therapy for axial skeletal metastases

AU - Romano, Kara D.

AU - Trifiletti, Daniel

AU - Bauer-Nilsen, Kristine

AU - Wages, Nolan A.

AU - Watkins, William T.

AU - Read, Paul W.

AU - Showalter, Timothy N.

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Purpose Palliative radiation therapy (RT) for bone metastases has traditionally been delivered with conventional, nonconformal RT (NCRT). Conformal RT (CRT) is potentially more complex and expensive than NCRT, but may reduce normal tissue dose and subsequently toxicity. In this retrospective analysis, we compared CRT with NCRT to investigate the association between conformality and toxicity. Methods and materials A retrospective analysis of patients receiving palliative RT for axial skeletal bone metastases from 2012 to 2014 was conducted. Patient and treatment characteristics were obtained including dosimetric variables, acute toxicity, and subjective pain during treatment and in the acute posttreatment period (≤60 days after completion). Statistical analyses included t tests, χ2 tests, and multivariate logistic regression. Results A total of 179 patients and 254 bone metastases were identified (142 CRT, 112 NCRT). The CRT and NCRT groups were well matched for baseline characteristics (number of fractions, field size, treatment sites, and concurrent chemotherapy). In multivariate logistic regression models, technique (CRT vs NCRT) was not associated with development of acute toxicity. Regarding toxicity, Eastern Cooperative Oncology Group performance status and total dose were significantly associated with a higher rate of acute toxicity during RT (odds ratios, 0.649 and 1.129 and P = .027 and .044, respectively), and only a higher number of vertebral bodies in the treatment field was significantly associated with acute toxicity post-treatment (odds ratios, 1.219, P = .028). CRT was associated with improvement in bone pain during and posttreatment (P = .049 and .045, respectively). Conclusions Our results demonstrate no difference in acute toxicity following palliative RT with CRT compared with NCRT for painful bone metastases; however, treatment volume did predict for increased toxicity. Larger studies may further elucidate the value of CRT including the impact of dose escalation for bone metastases and differences in patient reported outcomes between RT techniques.

AB - Purpose Palliative radiation therapy (RT) for bone metastases has traditionally been delivered with conventional, nonconformal RT (NCRT). Conformal RT (CRT) is potentially more complex and expensive than NCRT, but may reduce normal tissue dose and subsequently toxicity. In this retrospective analysis, we compared CRT with NCRT to investigate the association between conformality and toxicity. Methods and materials A retrospective analysis of patients receiving palliative RT for axial skeletal bone metastases from 2012 to 2014 was conducted. Patient and treatment characteristics were obtained including dosimetric variables, acute toxicity, and subjective pain during treatment and in the acute posttreatment period (≤60 days after completion). Statistical analyses included t tests, χ2 tests, and multivariate logistic regression. Results A total of 179 patients and 254 bone metastases were identified (142 CRT, 112 NCRT). The CRT and NCRT groups were well matched for baseline characteristics (number of fractions, field size, treatment sites, and concurrent chemotherapy). In multivariate logistic regression models, technique (CRT vs NCRT) was not associated with development of acute toxicity. Regarding toxicity, Eastern Cooperative Oncology Group performance status and total dose were significantly associated with a higher rate of acute toxicity during RT (odds ratios, 0.649 and 1.129 and P = .027 and .044, respectively), and only a higher number of vertebral bodies in the treatment field was significantly associated with acute toxicity post-treatment (odds ratios, 1.219, P = .028). CRT was associated with improvement in bone pain during and posttreatment (P = .049 and .045, respectively). Conclusions Our results demonstrate no difference in acute toxicity following palliative RT with CRT compared with NCRT for painful bone metastases; however, treatment volume did predict for increased toxicity. Larger studies may further elucidate the value of CRT including the impact of dose escalation for bone metastases and differences in patient reported outcomes between RT techniques.

UR - http://www.scopus.com/inward/record.url?scp=85021710003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021710003&partnerID=8YFLogxK

U2 - 10.1016/j.prro.2017.04.002

DO - 10.1016/j.prro.2017.04.002

M3 - Article

C2 - 28666907

AN - SCOPUS:85021710003

VL - 7

SP - e479-e487

JO - Practical Radiation Oncology

JF - Practical Radiation Oncology

SN - 1879-8500

IS - 6

ER -